Company profile: Ergomed
1.1 - Company Overview
Company description
- Provider of specialized services to the pharmaceutical industry and the development of new drugs, operating two complementary businesses, including a well-established clinical research business providing services to the pharmaceutical and biotechnology.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ergomed
Patheon
HQ: United States
Website
- Description: Provider of commercial manufacturing and pharmaceutical development services to pharmaceutical and biotechnology industries worldwide, spanning solid, semi-solid, liquid, and sterile dosage forms. Offers contract development and manufacturing from preclinical to commercialization, clinical trial strategy and operations, commercial services, advanced therapies (viral vectors, cell therapy, mRNA), biologics, and small molecule development and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Patheon company profile →
Uquifa
HQ: Spain
Website
- Description: Provider of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and custom synthesis services for the pharmaceutical industry. Operates three cGMP manufacturing sites (two in Spain, one in Mexico) inspected and approved by major pharmaceutical companies and regulatory authorities, including the US FDA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Uquifa company profile →
Base Life Science
HQ: Denmark
Website
- Description: Provider of information technology consulting and solutions, including the BASE Migration Framework for complex, compliant data migrations; Veeva Development Cloud services for process strategy, implementation, training, and post-implementation support; clinical process optimization, system training and implementation (CDMS, eTMF, CTMS); and CRO onboarding and oversight.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Base Life Science company profile →
BioStrata
HQ: United Kingdom
Website
- Description: Provider of life science marketing services delivered by a team fluent in scientific and business languages, including brand awareness, lead generation and customer conversion; scientific and technical content creation; SEO (keyword research, content optimization, performance tracking); public relations; and marketing strategy development based on market research and tactical planning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioStrata company profile →
Validant
HQ: United States
Website
- Description: Provider of quality, manufacturing, engineering, and regulatory compliance expertise to biotechnology and pharmaceutical companies, delivering regulatory affairs (pre- and post-market), quality management systems, internal audits and inspection readiness, pharmacovigilance, IT and data integrity assessments and execution, and support for CDMO/CMO vs in-house production decisions via a versatile, rapidly deployable expert network.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Validant company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ergomed
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ergomed
2.2 - Growth funds investing in similar companies to Ergomed
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ergomed
4.2 - Public trading comparable groups for Ergomed
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →